Global Epidemiology of Viral Hepatitis
- PMID: 32389357
- DOI: 10.1016/j.gtc.2020.01.001
Global Epidemiology of Viral Hepatitis
Abstract
Viral hepatitis (A, B, C, D, and E) is the leading cause of inflammation of liver tissue (hepatitis). The disease burden associated with hepatitis A and E occurs shortly after infection; it is more severe among adults. With hepatitis A and E, the number of incident cases (new acute infections) is important from a public health perspective. Long-term hepatitis has been shown to cause cirrhosis and hepatocellular carcinoma in patients. The disease burden associated with hepatitis B, C, and D appears 10 to 20 years after infection. Thus, the prevalence of these infections is important from a public health perspective.
Keywords: Epidemiology; Global; HBV; HCV; Hepatitis B; Hepatitis C; Viral hepatitis.
Copyright © 2020 Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosure H. Razavi is a member of advisory boards for Gilead, AbbVie, and Merck. All proceeds go to the Center for Disease Analysis Foundation. He is the managing director of the Center for Disease Analysis (CDA) and the Center for Disease Analysis Foundation (CDAF). In the last 3 years, CDA has received research funding from Gilead, AbbVie, Pfizer, Intercept, and Vaccine Impact Modeling Consortium. CDAF has received grants from CDC Foundation, John Martin Foundation, ASTHO, Zeshan Foundation, and Private donors.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical